nicotinamide mononucleotide has been researched along with Brain Hemorrhage in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, MH; Hua, X; Kong, YY; Li, GQ; Miao, CY; Wang, P; Wei, CC; Zheng, SL | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Brain Hemorrhage
| Article | Year |
|---|---|
NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Intracranial Hemorrhages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; NAD; Nicotinamide Mononucleotide; Tight Junction Proteins; Tissue Plasminogen Activator | 2017 |